Matsuda, Eriko, Obama, Yuki, Kosai, Ken-ichiro (2021) Safe and low-dose but therapeutically effective adenovirus-mediated hepatocyte growth factor gene therapy for type 1 diabetes in mice. Life Sciences, 268. 119014pp. doi:10.1016/j.lfs.2020.119014
| Reference Type | Journal (article/letter/editorial) | ||
|---|---|---|---|
| Title | Safe and low-dose but therapeutically effective adenovirus-mediated hepatocyte growth factor gene therapy for type 1 diabetes in mice | ||
| Journal | Life Sciences | ||
| Authors | Matsuda, Eriko | Author | |
| Obama, Yuki | Author | ||
| Kosai, Ken-ichiro | Author | ||
| Year | 2021 (March) | Volume | 268 |
| Publisher | Elsevier BV | ||
| DOI | doi:10.1016/j.lfs.2020.119014Search in ResearchGate | ||
| Generate Citation Formats | |||
| Mindat Ref. ID | 13602129 | Long-form Identifier | mindat:1:5:13602129:4 |
| GUID | 0 | ||
| Full Reference | Matsuda, Eriko, Obama, Yuki, Kosai, Ken-ichiro (2021) Safe and low-dose but therapeutically effective adenovirus-mediated hepatocyte growth factor gene therapy for type 1 diabetes in mice. Life Sciences, 268. 119014pp. doi:10.1016/j.lfs.2020.119014 | ||
| Plain Text | Matsuda, Eriko, Obama, Yuki, Kosai, Ken-ichiro (2021) Safe and low-dose but therapeutically effective adenovirus-mediated hepatocyte growth factor gene therapy for type 1 diabetes in mice. Life Sciences, 268. 119014pp. doi:10.1016/j.lfs.2020.119014 | ||
| In | (2021) Life Sciences Vol. 268. Elsevier BV | ||
See Also
These are possibly similar items as determined by title/reference text matching only.
